The push toward utilizing IoT

Cara Livernois | | Health Exec | Economics

The “internet of things” (IoT) is the bright future of connected technology, yet remains underutilized by healthcare organizations. In a preview of a Healthcare Financial Management Association (HFMA) conference presentation by Paul Perry, director of Warren Averett security services, IoT is highlighted for its benefits with connected health.

In one specific example, Perry explains how IoT was used to solve the mystery of the sick nurses. When nurses began taking additional sick days, patient satisfaction scores were dropping due to the use of fill-in nurses. When analyzing the connected technology within hand sanitizer stations, it was discovered the nurses were slacking on hand hygiene and getting sick more often.

“Because everything’s connected and everything’s tracking everything we’re doing, we should be able to use that data, analyze it and figure out why certain scenarios are occurring,” said Perry.

Read the full story below at HealthExec:

HFMA 2017 preview: What the ‘internet of things’ can do for healthcare finance

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations
Cleerly’s momentum continues as AI specialists raise $106M
Operations manager, doctors charged in $70M imaging kickback scheme
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.